Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: QDEL

QuidelOrtho Corporation

Healthcare | Medical - Instruments & Supplies

No licensed closing price on file for QDEL. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (FY2025)$-16.69

QuidelOrtho Corporation (NASDAQ: QDEL) is a medical instruments and supplies company. Figures from SEC EDGAR; updated 2026-10-20 09:48 UTC.

What QuidelOrtho Corporation does

QuidelOrtho Corporation is a diagnostics company that develops and sells testing solutions for clinical laboratories, hospitals, physician offices, and point-of-care settings across multiple countries. The company operates through five business units—Labs, Transfusion Medicine, Point of Care, Molecular Diagnostics, and non-core revenue streams—using expertise in immunoassay, molecular testing, clinical chemistry, and transfusion medicine. It manufactures products globally and sells them both directly and through distributors to healthcare providers and consumers.

Summarized from QuidelOrtho Corporation’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (FY2025)$-16.69
Debt/equity1.38

Revenue, margins & earnings

FY2021 Net income: $704MFY2021 Taxes & interest: $202MFY2021 Operating costs: $793M$1.70BFY2021FY2022 Net income: $549MFY2022 Taxes & interest: $295MFY2022 Operating costs: $2.42B$3.27BFY2022FY2023: net loss $10M on revenue $3.00B$3.00BFY2023FY2024: net loss $2.05B on revenue $2.78B$2.78BFY2024FY2025: net loss $1.13B on revenue $2.73B$2.73BFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-19
  • 2026-10-19EVP of R&D & CTOTax withholding-6,695$93.1K
  • 2026-10-19EVP of R&D & CTORestricted Stock UnitsOption exercise-18,657—
  • 2026-10-19EVP of R&D & CTOOption exercise18,657—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does QuidelOrtho Corporation do?

QuidelOrtho Corporation is a diagnostics company that develops and sells testing solutions for clinical laboratories, hospitals, physician offices, and point-of-care settings across multiple countries.

When did QDEL last file with the SEC?

QuidelOrtho Corporation's most recent SEC filing on record is a 8-K filed 2026-06-23. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 09:48 UTC. This page is also available as JSON at /api/data?ticker=QDEL and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for QDEL and 5,000+ tickers.

Create a free account — keep QDEL
For your agent
GET /api/data?ticker=QDEL

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt